GLPwatch
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
NCT04829903 · Completed
Last updated 2026-05-28This clinical trial compares two diabetes medications, dulaglutide and liraglutide, in overweight or obese adolescents with type 2 diabetes who are already taking metformin.
Status Completed The study has finished.
Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).
Type Interventional (clinical trial)
Design Randomized, quadruple-blind treatment study
Participants 116 people
Who can join Ages 12–19 · all sexes
Timeline Started 2020-01 · est. completion 2021-11
Where 1 site · Pakistan
What this study is testing ClinicalTrials.gov NCT04829903 ↗
Description as written by the study sponsor.
To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin
Treatments tested
- Dulaglutide also known as Group DUL Drug
Dulaglutide injections
- Liraglutide also known as Group LIR Drug
Liraglutide injections
| Main thing measured | Glycemic level |
|---|---|
| Sponsor | Corporacion Parc Tauli |
| Conditions studied | Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity |
| GLP-1 drugs | liraglutide, dulaglutide |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT04829903 ↗